Fund Holdings — Cormorant Asset Management, LP

Total Portfolio Value:
$2.09B
Total Bought:
$705.61M
Total Sold:
$461.83M
Net Transaction:
+$243.79M
Notable People:
Bihua Chen, Cormorant Asset Management Gp,
Securities
▲▼
SharesValue
Q3 2023
▲▼
Q4 2023
▲▼
Change
▲▼
Q3 2023
▲▼
Q4 2023
▲▼
Weight (%)
▲▼
Change
▲▼
MoonLake ImmunotherapeuticsCL A(MLTX)8,142,1008,494,151+352,051$464.10M$512.96M24.56%+$48.86M
Ambrx Biopharma Inc011,231,000+11,231,000$0$159.93M7.66%+$159.93M
EyePoint, Inc.(EYPT)3,200,0006,038,235+2,838,235$25.57M$139.54M6.68%+$113.98M
BridgeBio Pharma, Inc.(BBIO)4,662,5303,344,179-1,318,351$122.95M$135.00M6.46%+$12.05M
Arcellx Inc
COMMON STOCK
2,150,0001,700,000-450,000$77.14M$94.35M4.52%+$17.21M
Rayzebio Inc1,182,2631,213,478+31,215$26.25M$75.44M3.61%+$49.20M
Biomea Fusion, Inc.(BMEA)3,570,8723,570,8720$49.14M$51.85M2.48%+$2.71M
Immunovant, Inc.(IMVT)1,225,0001,165,000-60,000$47.03M$49.08M2.35%+$2.05M
Alpine Immune Sciences Inc1,900,0002,550,000+650,000$21.75M$48.60M2.33%+$26.85M
Pharvaris N V
COM
1,361,4601,711,460+350,000$28.41M$48.01M2.30%+$19.59M
ALX Oncology Holdings Inc.(ALXO)612,0793,142,079+2,530,000$2.94M$46.79M2.24%+$43.85M
Tarsus Pharmaceuticals, Inc.(TARS)2,621,4222,221,422-400,000$46.58M$44.98M2.15%-$1.60M
Cymabay Therapeutics Inc3,850,0001,800,000-2,050,000$57.40M$42.52M2.04%-$14.89M
Vaxcyte, Inc.(PCVX)665,000665,0000$33.90M$41.76M2.00%+$7.86M
Crinetics Pharmaceuticals In1,101,9041,150,000+48,096$32.77M$40.92M1.96%+$8.15M
Apellis Pharmaceuticals Inc
COM
2,000,000625,000-1,375,000$76.08M$37.41M1.79%-$38.67M
Marinus Pharmaceuticals Inc2,625,0003,250,000+625,000$21.13M$35.33M1.69%+$14.20M
Autolus Therapeutics plcADS(AUTL)392,1675,450,000+5,057,833$913.7K$35.10M1.68%+$34.18M
Olema Pharmaceuticals, Inc.(OLMA)4,504,7642,456,800-2,047,964$55.63M$34.47M1.65%-$21.16M
Immuneering CorpCL A4,204,3644,204,3640$32.29M$30.90M1.48%-$1.39M
Edgewise Therapeutics, Inc.(EWTX)2,946,8872,551,989-394,898$16.89M$27.92M1.34%+$11.03M
Aerovate Therapeutics Inc1,561,6961,211,696-350,000$21.19M$27.42M1.31%+$6.23M
Cargo Therapeutics Inc01,182,563+1,182,563$0$27.38M1.31%+$27.38M
Syndax Pharmaceuticals, Inc.(SNDX)01,175,000+1,175,000$0$25.39M1.22%+$25.39M
Korro Bio, Inc.(KRRO)0529,170+529,170$0$25.36M1.21%+$25.36M
Rhythm Pharmaceuticals, Inc.(RYTM)850,000550,000-300,000$19.49M$25.28M1.21%+$5.80M
ABIVAX Société AnonymeADS(ABVX)02,130,000+2,130,000$0$22.79M1.09%+$22.79M
Harpoon Therapeutics Inc54,0602,349,060+2,295,000$217.9K$22.55M1.08%+$22.33M
Spyre Therapeutics, Inc.(SYRE)0937,080+937,080$0$20.17M0.97%+$20.17M
Insmed Incorporated(INSM)575,000575,0000$14.52M$17.82M0.85%+$3.30M
IDEAYA Biosciences, Inc.(IDYA)600,000450,000-150,000$16.19M$16.01M0.77%-$177.0K
Axonics Inc250,000250,0000$14.03M$15.56M0.74%+$1.53M
Neurogene Inc.(NGNE)0746,180+746,180$0$14.46M0.69%+$14.46M
Longboard Pharmaceuticals In2,353,1412,353,1410$13.08M$14.19M0.68%+$1.11M
Praxis Precision Medicines, Inc.(PRAX)0633,345+633,345$0$14.11M0.68%+$14.11M
Rocket Pharmaceuticals, Inc.(RCKT)450,000450,0000$9.22M$13.49M0.65%+$4.27M
Rapt Therapeutics Inc325,000496,750+171,750$5.40M$12.34M0.59%+$6.94M
Disc Medicine, Inc.(IRON)225,000125,000-100,000$10.57M$7.22M0.35%-$3.35M
Stoke Therapeutics, Inc.(STOK)1,087,8071,087,8070$4.29M$5.72M0.27%+$1.44M
Verve Therapeutics Inc350,000350,0000$4.64M$4.88M0.23%+$238.0K
Lantheus Holdings, Inc.(LNTH)075,000+75,000$0$4.65M0.22%+$4.65M
Centessa Pharmaceuticals PlcADS561,600561,6000$3.63M$4.47M0.21%+$836.8K
Biohaven Ltd.(BHVN)81,96381,9630$2.13M$3.51M0.17%+$1.38M
GH Research PLC(GHRS)593,043593,0430$5.96M$3.44M0.16%-$2.52M
Yarrow Bioscience Inc(YARW)01,394,336+1,394,336$0$3.25M0.16%+$3.25M
BioAtla, Inc.(BCAB)1,181,1151,181,1150$2.01M$2.91M0.14%+$897.6K
Neumora Therapeutics, Inc.(NMRA)92,29392,2930$1.30M$1.57M0.08%+$271.3K
AMBRX BIOPHARMA INCSPONSORED ADS9,923,6890-9,923,689$114.12M$0—-$114.12M
AVIDITY BIOSCIENCES INCCOM1,762,1150-1,762,115$11.24M$0—-$11.24M
CABALETTA BIO INCCOM(CABA)2,879,4240-2,879,424$43.82M$0—-$43.82M
COGENT BIOSCIENCES INCCOM(COGT)1,000,0000-1,000,000$9.75M$0—-$9.75M
ENLIVEN THERAPEUTICS INCCOM1,216,7120-1,216,712$16.62M$0—-$16.62M
ERASCA INCCOM(ERAS)10,813,2460-10,813,246$21.30M$0—-$21.30M
KARUNA THERAPEUTICS INCCOM140,0000-140,000$23.67M$0—-$23.67M
ORCHARD THERAPEUTICS PLCSPON ADS NEW25,6640-25,664$198.4K$0—-$198.4K
PRAXIS PRECISION MEDICINES ICOM9,500,0000-9,500,000$16.25M$0—-$16.25M
STRUCTURE THERAPEUTICS INCSPONSORED ADS1,056,3730-1,056,373$53.26M$0—-$53.26M
VIGIL NEUROSCIENCE INCCOM616,7860-616,786$3.32M$0—-$3.32M
ZENTALIS PHARMACEUTICALS INCCOM(ZNTL)700,0000-700,000$14.04M$0—-$14.04M
Page 1 of 1
Cormorant Asset Management, LP — 13F Holdings — Q4 2023 | TickerTrail